Sökning: onr:"swepub:oai:DiVA.org:umu-40999" >
Two-year outcome of...
Two-year outcome of vagus nerve stimulation in treatment-resistant depression
-
Bajbouj, Malek (författare)
-
Merkl, Angela (författare)
-
Schlaepfer, Thomas E. (författare)
-
visa fler...
-
Frick, Caroline (författare)
-
Zobel, Astrid (författare)
-
Maier, Wolfgang (författare)
-
O'Keane, Veronica (författare)
-
Corcoran, Ciaran (författare)
-
- Adolfsson, Rolf (författare)
- University Hospital Umeå, Umeå, Sweden
-
Trimble, Michael (författare)
-
Rau, Harald (författare)
-
Hoff, Hans-Joachim (författare)
-
Padberg, Frank (författare)
-
Müller-Siecheneder, Florian (författare)
-
Audenaert, Kurt (författare)
-
van den Abbeele, Dirk (författare)
-
Matthews, Keith (författare)
-
Christmas, David (författare)
-
Eljamel, Sam (författare)
-
Heuser, Isabella (författare)
-
visa färre...
-
(creator_code:org_t)
- Lippincott Williams & Wilkins, 2010
- 2010
- Engelska.
-
Ingår i: Journal of Clinical Psychopharmacology. - : Lippincott Williams & Wilkins. - 0271-0749 .- 1533-712X. ; 30:3, s. 273-281
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- One of the major goals of antidepressant treatment is a sustained response and remission of depressive symptoms. Some of the previous studies of vagus nerve stimulation (VNS) have suggested antidepressant effects. Our naturalistic study assessed the efficacy and the safety of VNS in 74 European patients with therapy-resistant major depressive disorder. Psychometric measures were obtained after 3, 12, and 24 months of VNS. Mixed-model repeated-measures analysis of variance revealed a significant reduction (P < or = 0.05) at all the 3 time points in the 28-item Hamilton Rating Scale for Depression (HRSD28) score, the primary outcome measure. After 2 years, 53.1% (26/49) of the patients fulfilled the response criteria (> or =50% reduction in the HRSD28 scores from baseline) and 38.9% (19/49) fulfilled the remission criteria (HRSD28 scores < or = 10). The proportion of patients who fulfilled the remission criteria remained constant as the duration of VNS treatment increased. Voice alteration, cough, and pain were the most frequently reported adverse effects. Two patients committed suicide during the study; no other deaths were reported. No statistically significant differences were seen in the number of concomitant antidepressant medications. The results of this 2-year open-label trial suggest a clinical response and a comparatively benign adverse effect profile among patients with treatment-resistant depression.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Psykiatri (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Psychiatry (hsv//eng)
Nyckelord
- clinical trial
- Hamilton Rating Scale for Depression
- major depressive disorder
- depression
- vagus nerve stimulation
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Bajbouj, Malek
-
Merkl, Angela
-
Schlaepfer, Thom ...
-
Frick, Caroline
-
Zobel, Astrid
-
Maier, Wolfgang
-
visa fler...
-
O'Keane, Veronic ...
-
Corcoran, Ciaran
-
Adolfsson, Rolf
-
Trimble, Michael
-
Rau, Harald
-
Hoff, Hans-Joach ...
-
Padberg, Frank
-
Müller-Siechened ...
-
Audenaert, Kurt
-
van den Abbeele, ...
-
Matthews, Keith
-
Christmas, David
-
Eljamel, Sam
-
Heuser, Isabella
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Psykiatri
- Artiklar i publikationen
-
Journal of Clini ...
- Av lärosätet
-
Umeå universitet